Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Watchful Waiting 3 Trial (WW3)
NCT04095299Phase 3Recruiting
- Sponsor
- Vejle Hospital
- Start
- Jan 2020
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in rectal cancer (2 arms), sponsored by Vejle Hospital. Primary endpoint: Rectal preservation at two years at 2 years. Started Jan 2020; status: recruiting.
02
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT04095299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04095299.